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Biological control of agricultural, livestock and hu-
man pests has been undertaken successfully for centu-
ries. For example, the biological control of citrus insect 
pests by ants has been described from as early as the 
4th century AD in China (Hsi Han, cited in Wackers & 
van Rijn 2005). Biological control can be defined as the 
release into the environment of a biological agent to con-
trol a given pest through mechanisms such as predation, 
parasitism, herbivory or disease. In recent decades, more 
than 100 pest species have been targeted by the release 
of multiple biological control agents into the Australian 
environment. Iconic success include the release of myx-
oma virus to control rabbit populations (Saunders et al. 
2010), the release of Cactoblastis moths to control prick-
ley pear (Opuntia spp) (Dodd 1940), the introduction of 
dung beetles to manage cattle dung and the bush flies 
that breed in it (Edwards & Pavri 2007) and the control 
of floating Salvinia weed (Room et al. 1981) using the 
beetle Cyrtobagous singularis. 
Dengue fever is a viral disease estimated to affect 
50-100 million people annually and is primarily spread 
by the domestic mosquito Aedes aegypti (L.) (WHO 
2009). The proposed approach aims to use the bacterium 
Wolbachia as a biological control agent to prevent the 
transmission of viruses such as dengue. Wolbachia are 
intracellular endosymbiotic bacteria naturally present 
in a large number of insects and other arthropod species 
(Werren et al. 2008). Some Wolbachia strains are also 
described as symbionts of filarial nematodes that infect 
humans and cause diseases such as river blindness and 
elephantiasis (Bandi et al. 1998). However, there is cur-
rently some controversy as to whether the Wolbachia that 
infect filarial nematodes should be classified as a sepa-
rate species as their biology is quite distinct to the Wol-
bachia that infect insects (Pfarr et al. 2007). Wolbachia 
are able to actively spread into insect populations by ma-
nipulating insect reproduction (Werren et al. 2008). They 
are vertically transmitted across generations (via eggs) 
and confer reproductive advantages to infected females 
through a series of reproductive phenotypes that include 
cytoplasmic incompatibility, feminization, male killing 
or parthenogenesis (Werren et al. 2008). Wolbachia has 
long been considered as a potential biocontrol agent for 
insects and the pathogens they transmit, but has never 
been operationally deployed beyond pilot testing (Laven 
1967, Beard et al. 1993, Sinkins & O’Neill 2000, Rasgon 
et al. 2003, Brownstein et al. 2003, Cook et al. 2007).
Wolbachia as a biological control agent against 
mosquito-borne diseases
Dengue viruses, like most pathogens transmitted by 
mosquitoes, need a significant period of development 
in the insect vector, termed the extrinsic incubation 
period (EIP), before they can be transmitted to a new 
host (Watts et al. 1987). Since the EIP is long relative 
to average mosquito lifespan, the majority of pathogen 
transmission is done by old mosquitoes. In 1997, a Wol-
bachia strain was discovered with virulent properties in 
its natural host, Drosophila melanogaster, halving adult 
lifespan (Min & Benzer 1997). It has been proposed 
that this strain, wMelPop, could be a biological agent 
to reduce lifespan of mosquitoes therefore reducing the 
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Mosquito-borne diseases such as dengue fever, chikungunya or malaria affect millions of people each year and 
control solutions are urgently needed. An international research program is currently being developed that relies on 
the introduction of the bacterial endosymbiont Wolbachia pipientis into Aedes aegypti to control dengue transmission. 
In order to prepare for open-field testing releases of Wolbachia-infected mosquitoes, an intensive social research and 
community engagement program was undertaken in Cairns, Northern Australia. The most common concern expressed 
by the diverse range of community members and stakeholders surveyed was the necessity of assuring the safety of the 
proposed approach for humans, animals and the environment. To address these concerns a series of safety experiments 
were undertaken. We report in this paper on the experimental data obtained, discuss the limitations of experimental risk 
assessment and focus on the necessity of including community concerns in scientific research. 
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proportion of infectious mosquitoes (Sinkins & O’Neill 
2000, Brownstein et al. 2003, Cook et al. 2007). This 
strain has been successfully introduced into the dengue 
vector, Ae. aegypti, where it also reduces lifespan by up 
to 50%, while being maternally transmitted to 100% of 
the mosquito progeny (McMeniman et al. 2009). 
A number of recent independent studies have shown 
that wMelPop and other Wolbachia strains can also confer 
resistance against a wide range of insect viruses as well as 
important human pathogens such as dengue and chickun-
gunya viruses, Plasmodium gallinaceum, Plasmodium ber-
ghei or Brugia pahangi (Hedges et al. 2008, Teixeira et al. 
2008, Kambris et al. 2009, 2010, Moreira et al. 2009a, Gla-
ser & Meola 2010). This pathogen interference phenotype 
conferred by Wolbachia was observed in natural Drosophi-
la hosts as well as in artificially introduced hosts such as Ae. 
aegypti (Moreira et al. 2009a, T Walker et al., unpublished 
observations). The discovery of pathogen interference ef-
fects opened a new approach where instead of reducing 
mosquito lifespan to reduce infectious mosquitoes in a pop-
ulation, the utilisation of Wolbachia as a biocontrol agent 
could rely on direct pathogen interference. Interestingly, 
even though Wolbachia is estimated to infect 65% of insect 
species, including multiple mosquito species (from the ge-
nus Culex, Aedes, Coquillettidia, Mansonia and Uranotae-
nia) the major vectors of dengue and malaria (Ae. aegypti 
and various anopheline mosquitoes, respectively) are not 
naturally infected by Wolbachia (Kittayapong et al. 2000, 
Ricci et al. 2002, Rasgon & Scott 2004, Hilgenboecker et al. 
2008). The fact that many mosquito species are weak vec-
tors could be due to the presence of Wolbachia symbionts, 
an interesting hypothesis that needs to be verified and could 
then provide evidence for a “natural” example of biological 
control by Wolbachia.
The proposed approach of using Wolbachia infec-
tions of Ae. aegypti as a biological control approach for 
dengue transmission is nearing open field testing in the 
course of an international research program associating 
collaborators from Australia, Vietnam, Thailand, USA 
and Brazil (www.mosquitoage.org/en/HOME.aspx). If 
these strains can spread in natural populations as they 
do in the laboratory, they could be an effective control 
solution against dengue transmission. A trial release of 
Wolbachia-infected Ae. aegypti is proposed for the 2010-
2011 “wet season” in Cairns, Australia, prior to subse-
quent releases in Vietnam and Thailand.
Integrating community concerns in the scientific 
approach
Concomitantly with the scientific work on this ap-
proach, a social research and community engagement 
program was developed (2008-2009) and undertaken 
(2009-2010) in the city of Cairns - including the proposed 
release areas. Its aim was to develop an ethical, effective, 
culturally sensitive, stakeholder-directed framework for 
community engagement and authorisation that was sensi-
tive to different socio-political settings (D McNaughton, 
unpublished observations).
Using a mixed methods approach, extensive social 
research and engagement were used to examine (i) how 
communities at the potential release sites wished to be en-
gaged, (ii) what would constitute authorisation and (iii) 
acceptability and non-acceptability issues (McNaughton 
2009). The results of this research were then used to de-
velop a community engagement strategy and to develop 
mechanisms for addressing and responding to community 
questions and concerns (McNaughton et al. 2010, D Mc-
Naughton, unpublished observations).
“Community acceptability is critical to the future use 
and success of this program and public engagement, col-
laborative partnerships and community and regulatory 
authorisation have been recognised as an ‘ethical require-
ment’ of this type of project.” (Newman et al. 2006, La-
very et al. 2008, D McNaughton, unpublished observa-
tions). Engaging communities early and identifying any 
concerns is critical to ethical engagement. It also provides 
a window for the research team to respond more effec-
tively to community concerns, through new scientific 
experiments such as those described here as well as the 
creation of new communication materials, capacity build-
ing, education and ongoing engagement (D McNaughton, 
unpublished observations).
Social research into lay knowledge of dengue fever 
and acceptability of the Wolbachia method was under-
taken in 2008-2009. Qualitative techniques including fo-
cus groups, in-depth interviews, questionnaires and par-
ticipant observation were used initially to gauge the full 
range of views and then confirmed by data from quantita-
tive measures such as telephone surveys which used rep-
resentative population samples and randomised sampling 
techniques (McNaughton 2009, D McNaughton, unpub-
lished observations).
The most common community concerns related to the 
safety of the approach and its capacity for transfer, name-
ly: is the Wolbachia approach safe for people? Is it safe for 
animals and other organisms? Is it safe for the environ-
ment (D McNaughton, unpublished observations)?
Initially, these questions were answered by drawing 
on the large number of well-documented arguments in 
the extant literature, incorporating this information into 
communication materials and engagement activities. 
However, as these arguments rely on baseline knowl-
edge of the biology of Wolbachia, dengue virus and Ae. 
aegypti it was thought they may not in themselves be 
enough to reassure the community who, in some in-
stances, expected to be provided experimental data that 
would directly assess those risks. It was determined that 
answering these questions relied on experimental evalu-
ation as well as on previous data, available observations 
and knowledge of the approach.
Can Wolbachia affect/be transferred to humans? 
Baseline data
A major concern the community repeatedly ex-
pressed was whether Wolbachia could be transferred to 
humans through the bite of infected mosquitoes (D Mc-
Naughton, unpublished observations). Wolbachia are 
specialized endosymbionts that infect insects as well 
as spiders, mites, terrestrial crustaceans (Breeuwer & 
Jacobs 1996, Bouchon et al. 1998, Taylor & Hoerauf 
1999, Oh et al. 2000, Bandi et al. 2001, Rowley et al. 
2004). Wolbachia have never been found in humans or 
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other mammals, neither in birds, reptiles or fish. When 
Wolbachia were first discovered in the 1930’s they 
were suspected of being potential human rickettsial 
pathogens and were tested accordingly (Hertig 1936). 
Preparations from Wolbachia infected ovaries were 
injected into chicken embryos but Wolbachia did not 
grow. They were also injected into baby mice both in-
traperitoneally and intracerebrally without symptoms 
or mortality that could be attributed to Wolbachia. The 
conclusion of these studies was that Wolbachia was a 
non-pathogenic symbiont of insects (Hertig 1936).
Humans have been exposed to Wolbachia for thou-
sands of years. Wolbachia are extremely common in 
the environment naturally infecting a large range of 
insect species including pests of stored food products 
as well as insects that bite humans such as nuisance 
mosquitoes like Aedes albopictus and Culex quinque-
fasciatus. There is no evidence showing neither that 
residues of Wolbachia-infected insects in food prod-
ucts are harmful to humans nor are there any adverse 
effects reported from people being bitten by insects 
containing Wolbachia. In fact, as part of this project, 
human volunteers have been providing bloodmeals to 
Wolbachia-infected mosquitoes by using their own 
legs or arms, receiving thousands of bites without ad-
verse consequences. This number is far higher than 
the number of potential bites people in the release ar-
eas would receive following the release of Wolbachia-
infected mosquitoes. 
Ethics
The work reported in this manuscript used human 
volunteers for mosquito feeding as approved by the Uni-
versity of Queensland Human Ethical Committee - ap-
proval 2007001379. Written consent was obtained from 
each participant used for blood-feeding.
Can Wolbachia affect/be transferred to humans? 
Experimental assessment
Despite the evidence against negative effects of Wol-
bachia against humans, a number of experiments were 
undertaken to assess its potential transfer to humans and 
the potential development of an immune response spe-
cific to Wolbachia.
Transfer to humans? - One general concern is whether 
Wolbachia would be injected into the human body via the 
insect saliva during blood-feeding (D McNaughton, unpub-
lished observations). In order to detect the presence of Wol-
bachia) polymerase chain reaction (PCR) analysis of the 
Ae. aegypti mosquito saliva has been performed (Moreira 
et al. 2009b). PCR amplification of the Wolbachia wsp 
gene and the mosquito apyrase gene showed that despite 
Wolbachia is present in salivary glands, it is absent in the 
saliva (Moreira et al. 2009b). Even when the transposable 
element IS5, present in at least 13 copies within the bacte-
rial genome (Wu et al. 2004), was used as a very sensitive 
PCR target, no amplification was obtained. These negative 
PCR results are supported by the size of the intracellular 
Wolbachia (around 1-2 μm in diameter) and the diameter 
of mosquito salivary ducts (less than 1 μm), which indicate 
that even if Wolbachia was present in the secreted salivary 
fluid it would be unlikely to move freely through the sali-
vary ducts (Moreira et al. 2009b). Nevertheless, Wolbachia 
antigens or residues could be injected into humans during 
biting which could then potentially induce an immune re-
sponse.
Development of an immune response specific to Wol-
bachia? - We therefore investigated the antibody response 
specific to Wolbachia in the human volunteers that regu-
larly feed mosquito colonies. Sera from human volunteers 
that blood-fed repeatedly the Wolbachia-infected mosqui-
Fig. 1: Western blot analysis to detect any potential anti-Wolbachia antibody in human sera. Wolbachia (A) or mosquito thorax extracts (B) were 
run in a 12% SDS-PAGE and incubated with either human sera or anti-WSP (Wolbachia surface protein) antibody (A) or with human sera or 
mouse anti-mosquito saliva serum (B). Non blood-feeder (NBF)1 and NBF2 are sera from NBF volunteers. Blood-feeder (BF)1, BF5, BF6, BF7, 
BF8, BF9, BF12 are sera from BF volunteers. M: Kaleidoscope prestained standards (Bio-Rad). 
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to lab colonies being exposed to many thousands of bites 
over a four-year time frame were collected [blood-feeder 
(BF), n = 17] for immunological analysis. Sera from hu-
mans who never blood-fed any mosquito lab colony were 
also collected as negative controls [non blood-feeder 
(NBF) n = 5]. Both Western blot and enzyme-linked im-
munosorbent assays (ELISA), classically used in combi-
nation for accurate diagnostics of human diseases such 
as human immunodeficiency virus (Sax et al. 2010), were 
performed for immunological detection of any possible 
human antibody specific to Wolbachia antigens. 
For Western blots Wolbachia extracts were first load-
ed on SDS-PAGE gels and after blotting, membranes were 
incubated with either a rabbit anti-WSP (Wolbachia sur-
face protein) antibody or with the different human sera 
from volunteers (Fig. 1). A single band with the right 
size for the Wolbachia WSP protein (26 kDa) (Braig et 
al. 1998) was detected only when the blot was incubated 
with an anti-WSP antibody (Fig. 1A). This same band was 
not detected when blots were incubated with the human 
sera from either BFs (which would recognize potential 
Wolbachia antigens) or non BFs. As a control, extracts 
from Wolbachia-uninfected mosquitoes were loaded on 
gels and the blots were incubated with human sera or 
with a mouse anti-mosquito saliva antibody [developed 
as shown by Drahota et al. (2009)] to detect whether vol-
unteers were responding to mosquito bites (Fig. 1B). As 
previously shown (Orlandi-Pradines et al. 2007), most of 
the sera of exposed human subjects (BFs) recognized an 
Ae. aegypti protein of 45 kDa. Also, the majority of BFs 
responded to a smaller size band of around 37 kDa, which 
was previously named D7 (James et al. 1991) and has been 
shown to be recognized by exposed humans (Peng et al. 
1998). These data show that human volunteers that have 
been exposed to many thousands of bites from Wolbachia-
infected mosquitoes over prolonged periods of time have 
antibody responses to mosquito saliva but have not devel-
oped IgG antibodies specific to Wolbachia that could be 
detected by Western blot. 
ELISA was also carried out on the individual sera to 
detect and measure the IgG antibodies specific to Wol-
bachia antigens to complement and verify the Western 
blots. Wolbachia were purified and homogenized from ei-
ther Ae. aegypti cells or Drosophila flies using previously 
described protocol (McMeniman et al. 2008). The same 
purification protocol was applied to Wolbachia-uninfect-
ed Ae. aegypti cells and Drosophila to evaluate the IgG 
response specific to possible remaining insect antigens 
[background optical density (ODn)]. ELISA plates were 
coated with antigens and individual sera were added and 
incubated overnight. IgG detection was performed using a 
goat anti-human IgG antibody. Individual IgG levels spe-
cific to Wolbachia were expressed as difference of OD 
(∆OD) values and calculated according to the formula 
∆OD = ODw - ODn, where ODw represents the individu-
al measure of OD for each purified Wolbachia samples. 
Antigens coated on the ELISA plates were either 
Wolbachia extracts purified from Ae. aegypti cells (each 
well coated with purified Wolbachia from 3 x 104 cells) 
or Wolbachia extracts purified from Drosophila flies 
(each well coated with purified Wolbachia from 1 fly), 
along with their respective uninfected controls. For the 
two host backgrounds (either Ae. aegypti cells) (Fig. 2B) 
or Drosophila flies (Fig. 2C), no difference in the level 
of IgG specific to Wolbachia was detected between BFs 
and NBFs. As a control, Wolbachia-uninfected Ae. ae-
gypti salivary gland extracts were coated on the ELISA 
plates (each well coated with 1/10th of a single salivary 
gland extract) and incubated with human sera to detect 
any IgG response specific to mosquitoes (Fig. 2A). BFs 
presented significantly higher IgG level specific to A. 
aegypti salivary gland extracts compared to NBFs (p = 
0.0129), confirming the development of human antibody 
against mosquitoes as shown by the Western blot.
Both immunological investigations, Western blots 
and ELISA, show that humans repeatedly bitten by Wol-
bachia-infected Ae. aegypti develop antibodies against 
mosquitoes as already described for exposed humans, but 
do not develop IgG antibody against Wolbachia. All those 
results indicate that Wolbachia antigens are not injected 
into humans during the mosquito bloodmeal and therefore 
do not initiate an immune response in human host.
Can Wolbachia be transferred into the environment? 
Baseline data
Another major concern from the public is whether the 
release of Wolbachia infected mosquitoes would negative-
ly affect the environment, that is whether Wolbachia could 
be transferred to other organisms or become established in 
the soil (D McNaughton, unpublished observations).
As for the previous question, a large piece of evidence 
indicates that this risk is negligible. Wolbachia is not infec-
tious and is transmitted only vertically through the eggs 
from one generation to another (Werren et al. 2008). Wol-
bachia bacteria are obligate endosymbionts, that is, they 
Fig. 2: ELISA analysis to detect IgG antibody levels specific to Aedes ae-
gypti salivary glands or to Wolbachia antigens in human sera. Individu-
als difference of optical density (∆OD) values are shown for blood-feed-
ers (BF) and for non-blood-feeders (NBF) and bars indicate the median 
value. Results are presented according to antigens: Wolbachia-uninfect-
ed Ae. aegypti salivary gland extracts (A), Wolbachia extracts purified 
from Ae. aegypti cell culture (B) and Wolbachia extracts purified from 
Drosophila flies (C). NS: non significant. Asterisk means statistical dif-
ferences between groups (non parametric Mann Whitney test). 
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can only live inside the cytoplasm of their host’s cells and 
are not able to survive outside their host organism, and as 
such, they are not expected to persist in the environment 
outside the mosquitoes that carry them. Wolbachia will 
degrade together with mosquito bodies when they die and 
the residues will be indistinguishable from natural organic 
components and of no toxicological significance.
Transferring Wolbachia from flies into mosquitoes 
was a daunting task in the laboratory, which took several 
years. The recent success in obtaining transinfection of Ae. 
aegypti mosquitoes with the wMelPop strain (McMeni-
man et al. 2009) is believed to be due to the pre-adaptation 
of Wolbachia in Aedes tissue culture (McMeniman et al. 
2008). This strain, initially isolated from D. melanogaster 
flies, was maintained for three years in tissue culture cells 
and only after this passaging scheme a stable infection in 
Ae. aegypti was successfully established by embryonic 
microinjection (McMeniman et al. 2009). Subsequent 
analysis of this strain after serial passage has revealed a 
number of genetic changes that occurred during the adap-
tation process (unpublished observations) and that were 
probably critical for the establishment of Wolbachia-in-
fected mosquitoes. For some strains, the introduction of 
Wolbachia into a new host can be done without adaptation 
in cell line. Nevertheless, we believe that a successful in-
troduction will still require hundreds to thousands of mi-
croinjections before obtaining a stable infection, at least in 
mosquito species (T Walker, unpublished observations). 
The difficulty of generating Wolbachia infections in new 
species indicates that the risk of horizontal transfer of 
Wolbachia to other lower flies is negligible.
Additional indirect evidence comes from the fact that 
Wolbachia-infected and uninfected species can coexist in 
the same habitat or predate on each other without acquiring 
the infection. In Australia, Ae. aegypti inhabits the same 
larval habitat as its close relative Aedes notoscriptus, which 
is naturally infected with Wolbachia (unpublished observa-
tions). However, extensive surveys of Ae. aegypti in Austra-
lia and around the world have determined that Ae. aegypti 
is not naturally infected with Wolbachia (Kittayapong et al. 
2000, Ricci et al. 2002, Rasgon & Scott 2004). Despite the 
opportunity for Wolbachia to transfer naturally from Ae. 
notoscriptus to Ae. aegypti, which has been possible for the 
entire time that Ae. aegypti has been present in the Austra-
lian environment, that transfer has never happened.
An even larger natural experiment has been running 
in south east Asia where Ae. aegypti occurs in sympatry 
with Ae. albopictus. Again Ae. albopictus is naturally in-
fected with two Wolbachia strains (Sinkins et al. 1995, 
Zhou et al. 1998, Dobson et al. 2001), often inhabits the 
same larval containers as Ae. aegypti and it is known that 
both species will ingest smaller instars of the other spe-
cies. Again despite this close contact no natural transfer of 
Wolbachia has ever been reported from Ae. albopictus to 
Ae. aegypti. All these observations show that horizontal 
transmission does not occur easily or at a high frequency. 
These types of natural experiments do not provide evi-
dence to support the case for frequent horizontal transfer.
This poses the interesting question of how does Wol-
bachia establish in insect hosts naturally if it is so hard 
to establish infections in the laboratory? This has been a 
central question for the Wolbachia research community 
for many years and despite considerable energy trying to 
answer this question by numerous research groups, mech-
anisms of natural transfer remain unknown. The only 
recorded examples of natural horizontal transfers have 
been between different parasitoids superinfecting the 
same insect host (Heath et al. 1999, Huigens et al. 2000, 
2004). However this seems to be an unlikely explanation 
for a general mechanism. Furthermore parasitoids are not 
significant parasites of mosquitoes. The general consen-
sus of the scientific community is that natural horizontal 
transfer events are extremely rare and the wide distribu-
tion of Wolbachia among insects is explained by the many 
millions of years that Wolbachia is believed to have been 
associated with insects, which in turn has allowed time 
for numerous rare events to accumulate. 
Can Wolbachia be transferred into the environment? 
Experimental assessment 
However, despite this body of evidence, and be-
cause of the concerns expressed by the community in 
the social research, a number of studies were conduct-
ed to evaluate if Wolbachia could be transferred from 
mosquitoes to other species. The possible horizontal 
transfer to mosquito predators and non-predator spe-
cies or environments in the vicinity of the mosquitoes 
were evaluated. 
Transfer to mosquito predators
In order to test the potential transfer of Wolbachia 
from infected mosquitoes into their natural predators, we 
designed predation experiments using two different spi-
der species (Menemerus bivittatus and Pholcus phalan-
gioides), commonly found in the Australian environment. 
TABLE I
Screening for Wolbachia transfer from mosquitoes 
to their predators
Species
Wolbachia
detectiona
Mosquito
detectionb
Menemerus bivittatus 0/80 NA
Pholcus phalangioides 2/440 2/2
a: Wolbachia detection performed by polymerase chain re-
action (PCR) targeting the specific IS5 sequence. Primer 
sequences: IS5-F (5′-GTATCCAACAGATCTAAGC-3’) and 
IS5-R (5’-ATAACCCTACTCATAGCTAG-3′). PCR conditions: 
95ºC for 3 min followed by 35 cycles of 95ºC for 30 sec, 55ºC for 
30 sec, 72ºC for 1 min and a final extension at 72ºC for 10 min; 
b: whenever a sample was positive for Wolbachia DNA, it was 
also screened for the presence of mosquito DNA through PCR 
targeting the ribosomal protein gene RpS17. Primer sequences: 
RpS17F (5’-CTGGAGATTTTCCGTTGTCA-3’) and RpS17R 
(5’-GACACTTCCGGCACGTAGTT-3’). PCR conditions: 95ºC 
for 3 min followed by 35 cycles of 95ºC for 30 sec, 60ºC for 30 
sec, 72ºC for 1 min and a final extension at 72ºC for 10 min.
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Although some populations of these spiders contain Wol-
bachia infections (Rowley et al. 2004), the populations 
used in the experiments were not naturally infected, as 
determined by PCR using Wolbachia specific primers.
A first experiment was done using 80 jumping spi-
ders (M. bivittatus, Salticidae) captured in Brisbane 
QLD, Australia. They were kept in individual containers 
and fed for four weeks with Wolbachia-infected mosqui-
toes (10 mosquitoes/spider/week) followed by two weeks 
of feeding with uninfected mosquitoes to clear their guts 
from possible remaining undigested infected mosqui-
toes. Spiders were then killed by freezing and stored at 
-20ºC until DNA extraction and PCR screening.
A second experiment was done on daddy long-legs 
spiders (P. phalangioides, Pholcidae). The experimen-
tal set up was similar to the previous one but it was ex-
tended for a longer period and a higher number of indi-
viduals were used. Twenty specimens were captured in 
Brisbane QLD and placed in five cages (30 x 30 x 30 
cm). All cages contained males and at least one female 
in order to allow breeding. The spiders were fed with 
Wolbachia-infected mosquitoes during 16 weeks using 
up to 1,600 mosquitoes/cage/week as the population of 
spiders increased rapidly in all the cages. This feeding 
regime was followed by three weeks of feeding with un-
infected mosquitoes to clear the spider guts from possi-
ble remaining undigested infected mosquitoes. The 412 
spiders obtained after breeding and the 28 egg sacs pres-
ent on females were then killed by freezing and stored at 
-20ºC prior to DNA extraction and PCR screening.
No jumping spiders were found positive for Wolbachia 
at the end of the first experiment. Similarly, after being fed 
as the sole food supply with thousands of Wolbachia-infect-
ed mosquitoes for weeks, and breeding in those conditions, 
only two daddy long-legs were positive for Wolbachia se-
quences. However, those two spiders were also positive for 
mosquito DNA, indicating that residual undigested infected 
mosquitoes were present within the spiders (Table I). 
Overall, the experiments were done on more than 500 
spiders and more than 900 eggs (through the analysis of 
28 daddy long-legs egg sacs) from the two different spe-
cies (jumping spiders and daddy long-legs). Those re-
sults show that the transmission of Wolbachia from mos-
quitoes to their spider predators is not a common event 
and was not observed in this experimental survey.
A last experiment was then performed to verify 
that Wolbachia did not disseminate in the environ-
ment surrounding large numbers of infected mosqui-
toes. Samples were collected in the Mosquito Research 
Facility (Cairns), a semi-field fully enclosed outdoor 
greenhouse style laboratory designed and constructed 
specifically for this project (www.mosquitoage.org/en/
HOME.aspx.) in which thousands of Wolbachia-infect-
ed mosquitoes were bred for several months. The dif-
ferent samples collected were meant to represent a full 
variety of species or “environment” in which Wolba-
chia could have disseminated. Samples comprised soil 
samples, plant leaves and roots, earthworms and milli-
pedes, all collected from inside the enclosure. DNA ex-
traction from all the samples was then performed with 
appropriate protocols and the presence of Wolbachia in 
the samples was assessed by PCR targeting the specific 
IS5 Wolbachia genes.
The results of the screening done for the possible 
dissemination of Wolbachia to non-predator species 
and environmental samples show that no Wolbachia 
was detected in any of the samples collected in the 
semi-field cages where Wolbachia-infected mosquitoes 
were bred for months, neither in plants, soil, nor arthro-
pods living in the cages (Table II).
All together, the results of these experiments show 
that there is no transmission of the bacteria to any of 
the environmental samples studied. These results are in 
fact not surprising and are consistent with the obligate 
intracellular status of Wolbachia and its maternal verti-
cal transmission. One could say that the sample sizes 
of these experiments are such that very rare horizon-
tal transmission events would not have been detected. 
However we can be confident from these experiments 
that horizontal transfer of Wolbachia to non-targets 
does not occur at high frequency. 
Even if transfers did occur between individuals, the 
nature of Wolbachia invasions into insect populations is 
such that a critical threshold frequency of infection must 
be overcome before the Wolbachia infection can spread 
into a population. This threshold frequency relates direct-
ly to the fitness cost imposed by the Wolbachia infection 
on the host (Hoffmann & Turelli 1997, Turelli 2010) and 
in the case of the Wolbachia strains we have been working 
with, the threshold is estimated to fall between 0.2-0.45. 
That means that Wolbachia infection rate must exceed 
a local frequency of 20-45% before it can spread. The 
theory behind this prediction is explained in detail in the 
literature (Hoffmann & Turelli 1997, Turelli 2010). 
Finally the consequence of any horizontal transmis-
sion events that might establish in foreign species needs 
to be considered. It is known that Wolbachia infections 
are quite common in the natural environment in a range 
of insect species, more than 60% of insects are estimated 
to be infected by Wolbachia (Hilgenboecker et al. 2008), 
including mosquitoes that commonly bite people such 
as Ae. notoscriptus, Ae. albopictus, Cx. quinquefascia-
tus and stored grain pests such as Tribolium (Wade & 
Chang 1995) Cadra and Ephestia (Ikeda et al. 2003), 
which leave residues in human food and even iconic 
species such as the protected Cairns Birdwing butter-
TABLE II
Screening for Wolbachia dissemination from mosquitoes 
to the environment through polymerase chain reaction 
targeting the specific IS5 sequence
Sample type
Wolbachia
detection
Soil 0/40
Plants 0/40
Earthworms-millipedes 0/30
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fly. Furthermore, within houses people host the fruit fly 
D. melanogaster, which is infected worldwide with the 
wMel strain of Wolbachia, one of the strains used in this 
project (Zhou et al. 1998). Considering the wide distribu-
tion of Wolbachia and no indications that it is impacting 
negatively on infected insect populations we would con-
tend that the consequences of any harm arising from low 
probability transfer events would be negligible.
To implement or not to implement?
In conclusion, as it is our responsibility to insure that 
the “remedy will cause no harm”, and as community con-
cerns were centred upon safety and the possibility of Wol-
bachia transfer, a number of experiments were conducted 
to verify that the Wolbachia-based strategy to control 
mosquito-borne disease is safe for people, other organ-
isms and the environment. The results presented in this 
paper show that no experimental evidence of any negative 
impact of Wolbachia-infected mosquitoes was obtained. 
Assessing experimentally the potential consequences 
that could happen over a long-term period and large geo-
graphic scale could be a daunting task. Many questions 
related to long-term consequences can only be assessed 
once the release is done. Questions such as the evolution 
of the virus in response to the presence of Wolbachia, 
or the persistence of the virus blocking phenotype after 
generations in natural population are examples of key 
concerns for the scientific project and for the community 
but indeed require a priori the release to be answered. 
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